BioVentrix Announces 50th Clinical Case Milestone For Revivent Technology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN RAMON, Calif. & AALST, Belgium--(BUSINESS WIRE)--BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced the successful completion of it 50th clinical case using the Revivent™ Myocardial Anchoring System in a 74-year-old male patient at the OLV Hospital in Aalst, Belgium. The case comes on the heels of other successful cases performed recently in Germany, Italy, and the UK.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC